1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Lymphoblastic Lymphoma, Refractory: new trials by email Literature Review of Lymphoblastic Lymphoma, Refractory trials Research Report on Lymphoblastic Lymphoma, Refractory
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax Basket Trial for High Risk Hematologic Malignancies Venetoclax, Azacitidine, Cytarabine - Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary | Phase 1 | Recruiting | Andrew E. Place, MD | 30 | 2023-03-29 | 2026-03-12 |
Leukemia, Biphenotypic, Acute (1) · Myelodysplastic Syndromes (1) · Neoplasm Metastasis (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Bone Marrow Diseases (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Azacitidine (1) · Cortisone (1) · Cytarabine (1) · Dexamethasone (1) · Dexrazoxane (1) · Doxorubicin (1) · Hydrocortisone (1) · Leucovorin (1) · Methotrexate (1) · Vincristine (1) · asparaginase erwinia chrysanthemi recombinant (1) · calaspargase pegol (1) · dexamethasone 21-phosphate (1) · dexamethasone acetate (1) · hydrocortisone sodium phosphate (1)
United States (1)